InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
6
T+90 hit rate
43%
T+90 mean return
-1.7%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Curran Terrie, Chairman & CEO. Insider active across 3 companies, notably Myovant Sciences Ltd.. Aggregated, 25 filings have been recorded. Breakdown: 2 buys · 6 sells. Total volume traded: €979k. History available since 1 September 2021. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
5,778 shares0Common StockSEC:0001628280-26-042042:0
19,109 shares@ US$6.587713.6% of flowCommon StockSEC:0000950170-25-008348:0
8,687 shares@ US$10.8482100.0% of flowCommon StockSEC:0001787306-24-000155:0
33,848 shares@ US$11.7240.9% of flowCommon StockSEC:0000950170-24-084179:0
10,139 shares0Common StockSEC:0001787306-24-000103:0
16,851 shares@ US$9.1115.9% of flowCommon StockSEC:0000950170-24-036398:0
37,500 shares0Common StockSEC:0001209191-23-054346:0
200,000 sharesCommon StockSEC:0001209191-23-042454:0
4,375 shares0Common StockSEC:0001787306-23-000058:0
12,919 shares@ US$7.819910.4% of flowCommon StockSEC:0001209191-23-023751:0
Ideal exit: 1 Jan 2024 (T+270)
3,673 sharesCommon SharesSEC:0001209191-23-017716:0
1,436 shares@ US$8.54111.3% of flowCommon StockSEC:0001209191-23-016002:0
97,500 shares0Common StockSEC:0001209191-23-004341:0
1,526 shares@ US$9.601.6% of flowCommon StockSEC:0001209191-22-058619:0
9,859 shares0Common SharesSEC:0001209191-22-054817:0
7,500 shares0Common StockSEC:0001209191-22-048472:0
4,312 shares0Common StockSEC:0001567619-22-012323:0
12,000 shares0Common StockSEC:0001209191-22-031080:0
20,500 shares@ US$7.40660.015% mcap100.0% of flowCommon StockSEC:0001209191-22-029451:0
Ideal exit: 7 Feb 2023 (T+270)
41,250 shares0Common StockSEC:0001209191-22-004488
41,250 shares0Common StockSEC:0001209191-22-004488:0
4,850 shares@ US$7.6515.0% of flowCommon SharesSEC:0001209191-21-055667
4,850 shares@ US$7.6515.0% of flowCommon SharesSEC:0001209191-21-055667:0
11,373 shares@ US$7.6535.0% of flowCommon SharesSEC:0001209191-21-054758:0
11,373 shares@ US$7.6535.0% of flowCommon SharesSEC:0001209191-21-054758
25 of 25 declarations
About Curran Terrie
Terrie Curran is President and Chief Executive Officer at Myovant Sciences Ltd., Phathom Pharmaceuticals, Inc., and Arcutis Biotherapeutics, Inc. She leads these companies with a focus on innovation and growth. Her leadership is essential for the development of new treatments.
